Tag Archives: Japan

  • Advances in Pediatric Personalized Medicine Are Highlighted at Unique International Conference

    … a lot of medications work just for about 50% of the patients who take them, thus, personalized medicine shows high potential to transform the way in which they treat diseases. During the conference, different experts from academia, government, and the private sector in the US, Canada, and Japan shared their knowledge of clinical applications, bioethics, and the development of pediatric personalized medicine programs. Some of the clinical applications that were discussed were from the research …

  • Why the Pharmaceutical Industry Needs to Adapt to Emerging Markets

    … pharmaceutical markets in the world were the United States, Japan, and Europe, accounting for nearly 75% of the growth in the global pharmaceutical marketplace.  Now compare that to today, where these major markets only account for nearly 45% of the global pharmaceutical growth rate, whereas the emerging markets have jumped from 8% to nearly 30% in this same period.  And this trend is only suspected to grow. While Europe and the US and Japan, are seen as the major players in the pharmaceutical …

  • Experimental Obesity Drug Could Treat Diabetes

    Recently, an international team of researchers based in Texas and Japan, have been experimenting with an obesity treatment nicknamed “Fatostatin”, that has been shown to not only make mice lose weight, but also shows great promise in the treatment of diabetes, and even the lowering of cholesterol.  These scientists have identified a small molecule therapy program that alters the genetic code involved in the way the human body turns food into fat.  Because it has been proven to be effective …

  • U.S. Falls Behind Europe in Research and Drug Development

    … consumers. European research and development isn’t nearly as costly compared to the high cost of patent-protected drugs in the U.S. – this is where the U.S. falls short. The study examined new chemical entities (NCEs) from 1982 through 2003. These drugs (NCEs) are introduced to the world’s largest markets. The study focused on the percentage of drug research funds to the percentage of NCEs credited to the U.S., Europe and Japan.  Each area of research was measured for productivity. The …

  • Federal Funding For Biomedical Research

    … (public, but mostly private cash) than any other in the world. The lack of price controls for drugs in the U.S. allow for better profit margins that can be reinvested in R&D.  All in all, the R&D machine in the United States is working just fine and, as a matter of fact, is subsidizing drug and treatment development in the rest of the developed world, where universal healthcare, drug price controls, and other hindrances of market forces are preventing Western Europe, Canada or Japan – …